Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K

Medicine & Life Sciences

• 3-methylquercetin 100%
• Skin Neoplasms 64%
• Phosphatidylinositol 3-Kinase 63%
• Epidermal Growth Factor 15%
• Extracellular Signal-Regulated MAP Kinases 11%
• MAP Kinase Kinase Kinase 1 8%
• 90-kDa Ribosomal Protein S6 Kinases 8%
• Adenosine Triphosphate 8%
• Neoplastic Cell Transformation 8%
• 70-kDa Ribosomal Protein S6 Kinases 6%
• Mitogen-Activated Protein Kinase Kinases 5%
• Medicinal Plants 5%
• Flavonoids 5%
• Growth 5%
• Mitogen-Activated Protein Kinases 5%
• Fruit 4%
• Heterografts 4%
• Phosphotransferases 4%
• Epithelial Cells 3%
• Food 3%
• Phosphorylation 3%
• Carcinoma 3%
• In Vitro Techniques 2%
• Neoplasms 1%